RedHill Biopharma | RDHL - Operating Expenses


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

RedHill Biopharma

RedHill Biopharma reported $22.75M in Operating Expenses for its fiscal quarter ending in December of 2022.


Operating Expenses Change
Adamis Pharmaceuticals ADMP:US USD 7.88M 1.9M
Cara Therapeutics CARA:US USD 33.82M 753K
Cronos Group Inc CRON:CN USD 42.14M 31.65M
Intra Cellular Therapies ITCI:US USD 143.7M 8.42M
RedHill Biopharma RDHL:US USD 22.75M 1.91M